Michael Hsiao

21.3k total citations · 1 hit paper
429 papers, 16.7k citations indexed

About

Michael Hsiao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael Hsiao has authored 429 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 256 papers in Molecular Biology, 113 papers in Cancer Research and 89 papers in Oncology. Recurrent topics in Michael Hsiao's work include Cancer, Hypoxia, and Metabolism (41 papers), RNA modifications and cancer (40 papers) and MicroRNA in disease regulation (36 papers). Michael Hsiao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (41 papers), RNA modifications and cancer (40 papers) and MicroRNA in disease regulation (36 papers). Michael Hsiao collaborates with scholars based in Taiwan, United States and China. Michael Hsiao's co-authors include Tsung‐Ching Lai, Ru‐Shi Liu, Yu‐Chan Chang, Ming‐Hsien Chan, Chih‐Jen Yang, Ming‐Hsien Chien, Yi‐Hua Jan, Kuo‐Tai Hua, Pei‐Jung Lu and Alexander T.H. Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Michael Hsiao

423 papers receiving 16.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

2012 670 citations Tsung‐Ching Lai, Michael Hsiao et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Hsiao	9.7k	5.0k	3.0k	1.6k	1.6k	429	16.7k
Debabrata Mukhopadhyay	7.7k 0.8×	2.9k 0.6×	2.7k 0.9×	1.3k 0.8×	1.2k 0.7×	235	14.3k
Dong Wang	8.5k 0.9×	3.0k 0.6×	3.9k 1.3×	1.9k 1.2×	1.5k 1.0×	548	15.9k
Edouard C. Nice	9.5k 1.0×	2.2k 0.4×	4.6k 1.6×	2.0k 1.2×	1.5k 1.0×	304	17.3k
Carine Michiels	7.4k 0.8×	5.3k 1.0×	2.0k 0.7×	2.0k 1.3×	1.7k 1.1×	198	15.8k
Olivier Féron	12.1k 1.2×	6.6k 1.3×	2.3k 0.8×	2.0k 1.2×	2.0k 1.2×	303	24.3k
Arjan W. Griffioen	10.1k 1.0×	3.6k 0.7×	5.4k 1.8×	4.7k 2.9×	1.8k 1.2×	281	19.3k
Sandro Santagata	8.0k 0.8×	2.4k 0.5×	2.0k 0.7×	1.7k 1.1×	2.2k 1.4×	191	15.3k
Jing Liu	8.9k 0.9×	2.3k 0.5×	1.8k 0.6×	1.3k 0.8×	996 0.6×	564	15.4k
Lei Zheng	7.9k 0.8×	3.9k 0.8×	1.3k 0.4×	1.2k 0.7×	965 0.6×	430	13.7k
Min Wu	7.4k 0.8×	2.1k 0.4×	1.6k 0.5×	1.4k 0.9×	1.1k 0.7×	294	14.8k

Countries citing papers authored by Michael Hsiao

Since Specialization

Citations

This map shows the geographic impact of Michael Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hsiao more than expected).

Fields of papers citing papers by Michael Hsiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hsiao. The network helps show where Michael Hsiao may publish in the future.

Co-authorship network of co-authors of Michael Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hsiao. A scholar is included among the top collaborators of Michael Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hsiao. Michael Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Forn-Chia, Yu‐Chia Chen, Po‐Shun Wang, et al.. (2024). A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer. Cell Death and Disease. 15(5). 310–310. 5 indexed citations

Chang, Yu‐Chan, Chien‐Hsiu Li, Ming‐Hsien Chan, et al.. (2023). Overexpression of synaptic vesicle protein Rab GTPase 3C promotes vesicular exocytosis and drug resistance in colorectal cancer cells. Molecular Oncology. 17(3). 422–444. 7 indexed citations

Li, Chien‐Hsiu, Chih‐Yeu Fang, Ming‐Hsien Chan, et al.. (2023). The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers. The Journal of Pathology Clinical Research. 9(3). 165–181. 5 indexed citations

Yang, Yi‐Chieh, Wei‐Jiunn Lee, Jer‐Hwa Chang, et al.. (2020). Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non–Small Cell Lung Cancer. Cancer Research. 80(16). 3292–3304. 21 indexed citations

Chiou, Jean, Yu‐Chan Chang, Yuan‐Feng Lin, et al.. (2019). Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin. Cancer Research. 79(24). 6113–6125. 50 indexed citations

Chien, Ming‐Hsien, Wei‐Min Chang, Wei-Jiunn Lee, et al.. (2017). A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio. Molecular Cancer Therapeutics. 16(6). 1102–1113. 18 indexed citations

Liu, Chia‐Wen, Kuo‐Tai Hua, Kaichun Li, et al.. (2017). Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 16(7). 1421–1434. 48 indexed citations

Chen, Min-Wei, Ming‐Hsien Chien, Kuo‐Tai Hua, et al.. (2017). The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Cancer Research. 77(8). 1955–1967. 128 indexed citations

Chang, Wei‐Min, Yuan‐Feng Lin, Chia‐Yi Su, et al.. (2016). Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Cancer Research. 76(24). 7140–7150. 41 indexed citations

10.

Chang, Yi‐Wen, Ying-Jhen Su, Michael Hsiao, et al.. (2015). Diverse Targets of β-Catenin during the Epithelial–Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse. Cancer Research. 75(16). 3398–3410. 77 indexed citations

11.

Chien, Ming‐Hsien, Wei-Jiunn Lee, Tsu‐Yao Cheng, et al.. (2015). Keap1–Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein. Clinical Cancer Research. 21(20). 4719–4732. 41 indexed citations

12.

Hong, Chih-Chen, Pai‐Sheng Chen, Jean Chiou, et al.. (2014). miR326 Maturation Is Crucial for VEGF-C–Driven Cortactin Expression and Esophageal Cancer Progression. Cancer Research. 74(21). 6280–6290. 29 indexed citations

13.

Shiah, Shine‐Gwo, Jenn‐Ren Hsiao, Wei‐Min Chang, et al.. (2014). Downregulated miR329 and miR410 Promote the Proliferation and Invasion of Oral Squamous Cell Carcinoma by Targeting Wnt-7b. Cancer Research. 74(24). 7560–7572. 115 indexed citations

14.

Liu, Yu‐Peng, Luo-Ping Ger, Tai‐I Hsu, et al.. (2013). Carboxyl-Terminal Modulator Protein Positively Regulates Akt Phosphorylation and Acts as an Oncogenic Driver in Breast Cancer. Cancer Research. 73(20). 6194–6205. 24 indexed citations

15.

Liu, Yu‐Peng, Chih‐Jen Yang, Ming-Shyan Huang, et al.. (2012). Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling. Cancer Research. 73(1). 406–416. 180 indexed citations

16.

Hwang‐Verslues, Wendy W., Yi‐Cheng Chang, Chun-Chin Chen, et al.. (2012). Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway. Cancer Research. 72(18). 4652–4661. 115 indexed citations

17.

Su, Jen-Liang, Xiaoyun Cheng, Hirohito Yamaguchi, et al.. (2011). FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization. Cancer Research. 71(21). 6878–6887. 39 indexed citations

18.

Chen, Min-Wei, Kuo‐Tai Hua, Lin‐Hung Wei, et al.. (2010). H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Research. 70(20). 7830–7840. 297 indexed citations

19.

Su, Jen-Liang, Poshen B. Chen, Yi-Wen Chang, et al.. (2010). Downregulation of MicroRNA miR-520h by E1A Contributes to Anticancer Activity. Cancer Research. 70(12). 5096–5108. 51 indexed citations

20.

Lo, Chi‐Wen, Min‐Wei Chen, Michael Hsiao, et al.. (2010). IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer. Cancer Research. 71(2). 424–434. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact